Floatz logo

(+)-VINCRISTINE

Lymphoma, Low-grade

Eisai Inc.Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Lymphoma, Low-grade cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Eisai Inc.
Phase 2B
Inno-206
Eisai Inc.
Phase 2B
Denileukin Diftitox
Eisai Inc.
Phase 2CCC

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →